Picture of Dr Martens logo

DOCS Dr Martens News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMid CapContrarian

REG - Dr. Martens PLC - Result of AGM

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220714:nRSN5154Sa&default-theme=true

RNS Number : 5154S  Dr. Martens PLC  14 July 2022

14 July 2022

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

14 JULY 2022

The Company announces the results of voting at its Annual General Meeting held
earlier today and confirms that all resolutions were duly passed on a poll
with majorities as set out below.

Resolutions 1 to 15 were proposed as Ordinary Resolutions and resolutions 16
to 19 as Special Resolutions.

 Resolution                                                                      Votes        %       Votes Against  %     Votes        Votes Withheld  % Voting

For

Total

                            Capital Instructed

 01      Receive the 2022 Annual Report and Accounts                             813,848,188  100.00  0              0.00  813,848,188  783,563         81.36%
 02      Approve the Directors' Remuneration Report                              807,707,382  99.15   6,923,259      0.85  814,630,641  1,110           81.44%
 03      Approve the Final Dividend                                              811,746,252  99.65   2,885,099      0.35  814,631,351  400             81.44%
 04      Re-elect Paul Mason                                                     798,851,082  98.70   10,553,833     1.30  809,404,915  5,226,836       80.92%
 05      Re-elect Kenny Wilson                                                   809,826,477  99.41   4,804,764      0.59  814,631,241  510             81.44%
 06      Re-elect Jon Mortimore                                                  809,094,165  99.32   5,537,076      0.68  814,631,241  510             81.44%
 07      Re-elect Ian Rogers                                                     810,551,309  99.50   4,079,932      0.50  814,631,241  510             81.44%
 08      Re-elect Ije Nwokorie                                                   809,887,078  99.42   4,744,163      0.58  814,631,241  510             81.44%
 09      Re-elect Lynne Weedall                                                  791,704,376  97.19   22,926,665     2.81  814,631,041  710             81.44%
 10      Re-elect Robyn Perriss                                                  803,176,287  98.59   11,454,954     1.41  814,631,241  510             81.44%
 11      Re-elect Tara Alhadeff                                                  804,121,618  98.71   10,509,623     1.29  814,631,241  510             81.44%
 12      Appoint PricewaterhouseCoopers LLP as auditor                           813,775,770  99.89   855,681        0.11  814,631,451  300             81.44%
 13      Authorise the Audit & Risk Committee to determine the Auditor's         814,220,813  99.95   410,638        0.05  814,631,451  300             81.44%
         remuneration
 14      Authorise the Company and its subsidiaries to make political donations  809,153,872  99.33   5,476,763      0.67  814,630,635  1,116           81.44%
 15      Authorise allotment of shares                                           797,319,899  97.87   17,311,344     2.13  814,631,243  508             81.44%
 16      Authorise general disapplication of pre-emption rights*                 813,947,595  99.92   683,756        0.08  814,631,351  400             81.44%
 17      Authorise additional disapplication of pre-emption rights*              811,886,184  99.66   2,745,167      0.34  814,631,351  400             81.44%
 18      Authorise purchase of own shares*                                       813,899,052  99.95   446,465        0.05  814,345,517  286,234         81.41%
 19      Authorise calling of general meetings on 14 days' notice*               795,268,484  97.62   19,362,867     2.38  814,631,351  400             81.44%

*Special Resolution

The votes of independent shareholders on the resolutions concerning the
election or re-election of the Independent Non-Executive Directors are set out
below:

 Resolution                      Votes        %      Votes Against  %     Votes        Votes Withheld  % Independent

For

Total

                            Capital Instructed

 07      Re-elect Ian Rogers     440,608,869  99.08  4,079,932      0.92  444,688,801  510             70.55%
 08      Re-elect Ije Nwokorie   439,944,638  98.93  4,744,163      1.07  444,688,801  510             70.55%
 09      Re-elect Lynne Weedall  421,761,936  94.84  22,926,665     5.16  444,688,601  710             70.55%
 10      Re-elect Robyn Perriss  433,233,847  97.42  11,454,954     2.58  444,688,801  510             70.55%

 

Notes:

1. Votes "For" and "Against" are expressed as a percentage of votes received.

2. A "Vote withheld" is not a vote in law and is not counted in the
calculation of the votes "For" or "Against" a resolution.

3. As at 6.30pm on 12 July 2022 the Company had a total of 1,000,283,652
ordinary shares with voting rights in issue. The total independent voting
capital, used to calculate the votes of independent shareholders on
resolutions 7-10, was 630,341,212.

4. In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as
special business will shortly be available for inspection on the National
Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

Enquiries

Investors and analysts

Mark Blythman, Interim Director of Investor Relations
  +44 7570 871207

mark.blythman@drmartens.com (mailto:mark.blythman@drmartens.com)

Media
 

Gill Hammond, Director of
Communications                          +44 7384
214248

Maitland
     +44 20 7379 5151

Clinton Manning                                       +44
7711 972 662

Joanna Davidson                                      +44
7827 254 567

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Originally produced for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while
still celebrating their proud heritage and, six decades later, "Docs" or "DMs"
are worn by people around the world who use them as a symbol of empowerment
and their own individual attitude.

 

The Company successfully listed on the main market of the London Stock
Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250
index.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGGPUPWMUPPGGC

Recent news on Dr Martens

See all news